申请人:BANYU PHARMACEUTICAL CO., LTD.
公开号:EP1816136A1
公开(公告)日:2007-08-08
A compound represented by the following formula, or a pharmaceutically acceptable salt thereof is a ligand selective for GPR7:
Trp-Tyr-Lys-(X)n-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-
Gly-Leu-NH2
where n is an integer of 2 to 10, and X independently represents a group represented by -NH-(CH2)m-CO- (where m is an integer of 2 to 6), a group represented by the formula
(where 1 is 0 or 1) which may have a substituent, or the like.
下式所代表的化合物或其药学上可接受的盐是一种对 GPR7 具有选择性的配体:
Trp-Tyr-Lys-(X)n-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-
Gly-Leu-NH2
其中 n 是 2 至 10 的整数,X 独立地代表由-NH-(CH2)m-CO-(其中 m 是 2 至 6 的整数)代表的基团,由式-NH-(CH2)m-CO-(其中 m 是 2 至 6 的整数)代表的基团。
(其中 1 为 0 或 1)代表的基团,该基团可能具有取代基,或类似基团。